Remimazolam for sedation after heart surgery
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are in the intensive care unit after heart surgery and still have a breathing tube
- Your doctors expect the breathing tube can be removed within 2 days
- You are not pregnant or breastfeeding
- You have no known allergy to the study drug
- You do not have certain heart rhythm problems or very low heart rate or blood pressure
- You have not joined any other clinical trial in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a sedative medication called remimazolam helps patients on breathing machines (ventilators) in the ICU recover better and have fewer complications. You would receive this medication to keep you calm and comfortable while on the ventilator.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This trial compares two sedative medicines (remimazolam and propofol) given during heart ablation procedures. The study uses brain-wave monitoring to see which medicine provides better sedation and recovery. It's for people who are already scheduled for this procedure with a specific doctor.
This study tests whether remimazolam, a sedative medication, affects thinking and memory after heart surgery with a heart-lung machine. Researchers want to know if this drug is safer for the brain during major heart surgery in older adults.
This trial tests whether a medication called remimazolam can help prevent atrial fibrillation—a common, irregular heart rhythm that can happen after surgery. It focuses on people having a specific planned type of heart bypass surgery and checks if the study medication reduces postoperative rhythm problems.
This study tests whether a sedation drug called remimazolam can help protect your kidneys during liver or pancreas surgery. If you are having one of these surgeries, you might be able to join.
Hear when a new Remimazolam trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.